Literature DB >> 6401380

Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions.

M Nap, K A ten Hoor, G J Fleuren.   

Abstract

The demonstration of carcinoembryonic antigen (CEA) in serum and in tissue sections may be of value in diagnosis and follow-up of several malignant tumors. Anti-CEA sera, however, cross-react with normal antigens, also present in tumors. The staining patterns of three commercially produced anti-CEA sera were investigated on sections of benign and malignant tissues, using an indirect immunoperoxidase technic. All three anti-CEA sera tested showed cross-reactions. A rapid, simple, and reproducible immunoabsorption was developed. After absorption, the reactivity of the sera with normal colon mucosa and carcinomas of the colon remained positive, whereas sections of benign tissues were negative. Moreover, four of ten breast cancers, positive with unabsorbed antisera, became negative after absorption. These findings stress the importance of immunohistochemical negative and positive controls. The use of well-absorbed commercial anti-CEA sera can lead to more uniform results, exchangeability of results, and a better understanding of the value of this tumor marker.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401380     DOI: 10.1093/ajcp/79.1.25

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Human oesophageal submucosal glands. Their detection mucin, enzyme and secretory protein content.

Authors:  D Hopwood; G Coghill; D S Sanders
Journal:  Histochemistry       Date:  1986

2.  Immunohistochemistry in the diagnosis of malignant mesothelioma.

Authors:  M Pfaltz; B Odermatt; B Christen; J R Rüttner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.

Authors:  R N Poston; Y S Sidhu
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

4.  Morphological predictors of survival in advanced gastric carcinoma univariate and multivariate analysis.

Authors:  P Schmitz-Moormann; C Pohl; G W Himmelmann; K Neumann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Lectin binding properties of cells from serous effusion and peritoneal washing specimens.

Authors:  P W Shield
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

6.  Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.

Authors:  E Heyderman; S E Larkin; P J O'Donnell; A M Haines; P J Warren; A Northeast; A G Grant
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

7.  Immunohistochemical study of colorectal adenocarcinomas and adenomas with antibodies against carcinoembryonic antigen (CEA), CA19-9, keratin, alpha-tubulin and secretory component (SC).

Authors:  T Taguchi; H Kijima; T Mitomi; R Y Osamura
Journal:  Gastroenterol Jpn       Date:  1991-06

8.  Immunohistochemistry of carcinoembryonic antigen, secretory component and lysozyme in benign and malignant common bile duct tissues.

Authors:  H Nagura; Y Tsutsumi; K Watanabe; H Hasegawa; T Fujimoto; T Sugita; T Mitomi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

9.  Immunohistochemical evidence for the expression of the carcinoembryonic antigen by human thymic epithelial cells in vitro and in neoplastic conditions.

Authors:  W Savino; D Durand; M Dardenne
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

10.  Comparison between cell kinetical and immunohistochemical studies on carcinoma and atypia/dysplasia of urinary bladder mucosa.

Authors:  B Helpap; J Vogel; P Oehr; H D Adolphs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.